The world’s eyes are set on the 2016 edition of the Summer Olympics, which started in Rio de Janeiro last week. I had a look at how Biotech has been involved in the Olympics – and how it could define it in the future.
The Summer Olympics of 2016 have been marked by its fair share of controversy. And not by the slightly confusing fact that, technically, it’s now Winter in Brazil.
No, the Olympics have been fighting science – or at least science-related problems. These include the epidemic of Zika virus, how the Guanabara Bay probably needs a bioremediation miracle and, finally, doping.
There’s a lot of doping agents, most of them small molecules. But biologicals also have a place in doping. There’s one that stands out –